Author:
Choudhary Anjali,Singh Parul,Agarwal Shikha,Saxena Namrata,Bahuguna Nidhi
Publisher
Jaypee Brothers Medical Publishing
Reference22 articles.
1. 1. Azziz R, Marin C, Hoq L, et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 2005;90:4650–4658. DOI: 10.1210/jc.2005-0628.
2. 2. Choudhary A, Jain S, Chaudhari P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: Is there a rising incidence Int J Reprod Contracept Obstet Gynecol 2017;6(11):4971–4975. DOI: 10.18203/2320-1770.ijrcog20175010.
3. 3. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metabol 2006;91(2):492–497. PMID: 16249280.
4. 4. Ricardo Azziz. Controversy in clinical endocrinology. diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature. J Clin Endocrinol Metab 2006;91(3):781–785. DOI: 10.1210/jc.2005- 2153.
5. 5. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds). Polycystic Ovary Syndrome. Boston: Blackwell Scientific; 1992. pp. 377–384.